EUVIMEDOpdag EUVIMED
Open access

A cross‐sectional study of differences in medication for opioid use disorder receipt among pregnant people enrolled in Medicaid in Oregon, United States

Camille C Cioffi iD, Ann Martinez Acevedo, Deborah J Cohen, Menolly R Kaufman, Kea Parker, Mishka Terplan, Stephan R Lindner

Addiction · 2025

DOI: 10.1111/add.16752 ↗

At a glance

Journal article in Addiction, 2025. Written by Camille C Cioffi and 6 co-authors. Institution: Oregon Research Institute, Springfield, OR, USA. Major MEDLINE topics: Healthcare Disparities, Medicaid, Opiate Substitution Treatment, Opioid-Related Disorders. Cited 4 times so far (Crossref); 63 references. The full text is freely available in PubMed Central. Funded by: NIDA NIH HHS, NICHD NIH HHS, Eunice Kennedy Shriver National Institute of Child Health and Development of the National Institutes of Health.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background and Aims Medication is the gold standard to support a healthy pregnancy for pregnant people with opioid use disorder (OUD). This study measured inequities and differences in OUD medication treatment among pregnant people in Oregon, USA. Design, Setting, Participants and Measurements Our study population consisted of Medicaid enrollees across the US state of Oregon who had at least one live hospital birth between 2012 and 2020 and one diagnosis of OUD prenatally ( n = 4363). We measured differences in demographic characteristics (age, race, ethnicity, location) among those with and without medication for OUD in the prenatal through 3‐months postpartum period (any medication use, and by type), and compared exclusive methadone versus buprenorphine receipt. We report unadjusted and adjusted odds ratios.

Findings

Adjusted odds ratios for medication for OUD were lower among American Indian/Alaska Native pregnant people compared with White pregnant people [adjusted odds ratio (aOR) 0.59 (95% confidence interval [CI] = 0.42, 0.83)], younger pregnant people compared with those aged 30–34 years [aOR, ages 15–19: 0.1 (95 CI = 0.06, 0.18); aOR, ages 20–24: 0.58 (95 CI = 0.49, 0.69)] and rural pregnant people compared with those in urban communities [aOR 0.58 (95 CI = 0.5–0.67)]. Rural pregnant people with OUD also had lower odds of methadone receipt [aOR 0.23 (95 CI = 0.17, 0.3)] and higher odds of buprenorphine receipt [aOR 3.99 (95 CI = 2.97, 5.35)] than other people in this study. Among those who received medication, Black pregnant people had increased odds of receiving methadone compared with buprenorphine [aOR 2.09 (95 CI = 1.1–3.97)].

Conclusions

In Oregon, USA, inequities in receipt of any medication for opioid use disorder were observed among pregnant people who identified as American Indian or Alaska Native, younger than 25, and living in rural communities. Black pregnant people in Oregon, USA, were more likely to receive methadone than buprenorphine.

Subjects

MeSH terms (MEDLINE)

Healthcare DisparitiesMedicaidOpiate Substitution TreatmentOpioid-Related DisordersPregnancy ComplicationsAdolescentAdultFemaleHumansPregnancyYoung AdultAmerican Indian or Alaska NativeAnalgesics, OpioidBuprenorphineCross-Sectional StudiesMethadoneOregonUnited StatesWhite

Author keywords

MOUDbuprenorphinedisparitiesmedication for opioid use disordermethadonepregnancy

Substances

Analgesics, OpioidBuprenorphineMethadone

Authors and institutions

  • Oregon Research Institute, Springfield, OR, USA.
  • Prevention Science Institute, University of Oregon, Eugene, OR, USA.
  • Center for Health Systems Effectiveness, Department of Emergency Medicine, Oregon Health and Science University, Portland, OR, USA.
  • Department of Family Medicine, Oregon Health and Science University, Portland, OR, USA.
  • Friends Research Institute, Baltimore, MD, USA.
  • School of Public Health, Oregon Health and Science University-Portland State University, Portland, OR, USA.

ORCID profiles: Camille C Cioffi

Funding

  • NIDA NIH HHS
  • NICHD NIH HHS
  • Eunice Kennedy Shriver National Institute of Child Health and Development of the National Institutes of Health
  • National Institute of Child Health and Human Development

Cite

APA

Cioffi, C. C., Acevedo, A. M., Cohen, D. J., Kaufman, M. R., Parker, K., Terplan, M., & Lindner, S. R. (2025). A cross‐sectional study of differences in medication for opioid use disorder receipt among pregnant people enrolled in Medicaid in Oregon, United States. Addiction. https://doi.org/10.1111/add.16752

Vancouver

Cioffi CC, Acevedo AM, Cohen DJ, Kaufman MR, Parker K, Terplan M, et al. A cross‐sectional study of differences in medication for opioid use disorder receipt among pregnant people enrolled in Medicaid in Oregon, United States. Addiction. 2025. doi:10.1111/add.16752

BibTeX
@article{Cioffi2025,
  author = {Cioffi, Camille C and Acevedo, Ann Martinez and Cohen, Deborah J and Kaufman, Menolly R and Parker, Kea and Terplan, Mishka and Lindner, Stephan R},
  title = {A cross‐sectional study of differences in medication for opioid use disorder receipt among pregnant people enrolled in Medicaid in Oregon, United States},
  journal = {Addiction},
  year = {2025},
  doi = {10.1111/add.16752}
}
Start for free →